Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Moroctocog alfa 250unit inj vials
0211000I0AAAYAY
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 3,000unit inj pfs
0211000I0AAARAR
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 500unit inj pfs
0211000I0AAAUAU
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 500unit inj vials
0211000I0AABABA
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Multiparin 125,000units/5ml solution for injection vials
0208010K0BDACA6
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Multiparin 25,000units/5ml solution for injection vials
0208010K0BDABA5
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Multiparin 5,000units/5ml solution for injection vials
0208010K0BDAAA4
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Mysildecard 20mg tablets
0205010Y0BDAAAA
|
Mysildecard | Sildenafil(Vasodilator Antihypertensive) | Cardiovascular System | No data available |
|
Nadolol 100mg/5ml oral suspension
0204000M0AAALAL
|
Nadolol | Nadolol | Cardiovascular System | No data available |
|
Nadolol 30mg/5ml oral solution
0204000M0AAAFAF
|
Nadolol | Nadolol | Cardiovascular System | No data available |
|
Nadolol 40mg / Bendroflumethiazide 5mg tablets
0204000X0AAAAAA
|
Nadolol/bendroflumethiazide | Nadolol with diuretic | Cardiovascular System | No data available |
|
Nadolol 40mg/5ml oral solution
0204000M0AAACAC
|
Nadolol | Nadolol | Cardiovascular System | No data available |
|
Nadolol 80mg / Bendroflumethiazide 5mg tablets
0204000X0AAABAB
|
Nadolol/bendroflumethiazide | Nadolol with diuretic | Cardiovascular System | No data available |
|
Nadolol 80mg/5ml oral liquid
0204000M0AAAEAE
|
Nadolol | Nadolol | Cardiovascular System | No data available |
|
Naftidrofuryl 100mg/5ml oral solution
0206040AEAAAEAE
|
Naftidrofuryl | Naftidrofuryl oxalate | Cardiovascular System | No data available |
|
Navidrex 500microgram tablets
0202010J0BBAAAA
|
Navidrex | Cyclopenthiazide | Cardiovascular System | No data available |
|
Navispare 2.5mg/250microgram tablets
0202040A0BBAAAA
|
Navispare | Amiloride hydrochloride with thiazides | Cardiovascular System | No data available |
|
Nebbaro 1000mg capsules
0212000ABBFAAAA
|
Nebbaro | Omega-3-acid ethyl esters | Cardiovascular System | No data available |
|
Neo-Naclex 2.5mg tablets
0202010B0BEABAB
|
Neo-Naclex | Bendroflumethiazide | Cardiovascular System | No data available |
|
Neo-Naclex 5mg tablets
0202010B0BEAAAC
|
Neo-Naclex | Bendroflumethiazide | Cardiovascular System | No data available |
|
Neo-Naclex-K modified-release tablets
0202080B0BCAAAB
|
Neo-Naclex-K | Bendroflumethiazide/potassium | Cardiovascular System | No data available |
|
Neotren MR 400mg tablets
0206040AGBCAAAC
|
Neotren | Pentoxifylline | Cardiovascular System | No data available |
|
Nephril 1mg tablets
0202010X0BBAAAA
|
Nephril | Polythiazide | Cardiovascular System | No data available |
|
Niaspan 1g modified-release tablets
0212000U0BFACAX
|
Niaspan | Nicotinic acid | Cardiovascular System | No data available |
|
Niaspan 500mg modified-release tablets
0212000U0BFAAAV
|
Niaspan | Nicotinic acid | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.